Fabio Bertacchini, Senior Director of Product, Proposal and Technical account management at Stevanato Group shares how Ready-To-Use vials are answering pharma's call for solutions to aseptic manufacturing challenges.
Stevanato Group EZ-fill® vials – production line
Key insights:
- Stevanato's platform reduces the TCO by mitigating the cost of upstream operations, as well as reducing the costs and issues associated with lower quality solutions.
- RTU components enable total cost savings of up to 45% versus the conventional packaging containers over a period of 8-10 years.
- As the platform features no-glass-to-glass and no-glass-to-metal end to end, the integrity of pre-sterilised containers can be maximised throughout the manufacturing process.
Innovation and continuous improvement have always been cornerstones of the pharmaceutical industry. Supply chain partners who are invested in the research and delivery of innovative solutions, those that never stand still and are committed to support the success of their customers, tend to witness long term, sustainable growth.